Literature DB >> 16202407

The sclera and myopia.

Jody A Summers Rada1, Setareh Shelton, Thomas T Norton.   

Abstract

Myopia is a very common ocular problem, affecting perhaps one billion people worldwide. Most myopia is produced by lengthening of the vitreous chamber of the ocular globe. High myopia is characterized by scleral thinning and localized ectasia of the posterior sclera. The sclera is a dense, fibrous, viscoelastic connective tissue that forms the outer coat of the eye and consists of irregularly arranged lamellae of collagen fibrils interspersed with proteoglycans and non-collagenous glycoproteins. Scleral fibroblasts are located between scleral lamellae, and are responsible for synthesizing the extracellular matrix in which they reside. Research highlighted in this review clearly demonstrates that the sclera is not a static container of the eye, but rather is a dynamic tissue, capable of altering extracellular matrix composition and its biomechanical properties in response to changes in the visual environment to regulate ocular size and refraction. Based on these studies, a strategy directed at reversing myopia-associated scleral extracellular matrix remodeling events would be warranted, particularly in cases of high myopia in humans.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16202407     DOI: 10.1016/j.exer.2005.08.009

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  170 in total

1.  Protective effects of high ambient lighting on the development of form-deprivation myopia in rhesus monkeys.

Authors:  Earl L Smith; Li-Fang Hung; Juan Huang
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-01-25       Impact factor: 4.799

2.  Biomechanical changes in the sclera of monkey eyes exposed to chronic IOP elevations.

Authors:  Michaël J A Girard; J-K Francis Suh; Michael Bottlang; Claude F Burgoyne; J Crawford Downs
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-07-29       Impact factor: 4.799

3.  Thermomechanical stability of sclera after glyceraldehyde crosslinking.

Authors:  Gregor Wollensak
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-09-18       Impact factor: 3.117

4.  Fabrication and evaluation of chitosan-gelatin based buckling implant for retinal detachment surgery.

Authors:  Hui Chen; Zhi Zhao; Yahong Zhao; Yumin Yang
Journal:  J Mater Sci Mater Med       Date:  2010-08-14       Impact factor: 3.896

5.  Association of matrix metalloproteinase gene polymorphisms with refractive error in Amish and Ashkenazi families.

Authors:  Robert Wojciechowski; Joan E Bailey-Wilson; Dwight Stambolian
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-05-19       Impact factor: 4.799

6.  Birefringence imaging of posterior eye by multi-functional Jones matrix optical coherence tomography.

Authors:  Satoshi Sugiyama; Young-Joo Hong; Deepa Kasaragod; Shuichi Makita; Sato Uematsu; Yasushi Ikuno; Masahiro Miura; Yoshiaki Yasuno
Journal:  Biomed Opt Express       Date:  2015-11-19       Impact factor: 3.732

Review 7.  RPE and Choroid Mechanisms Underlying Ocular Growth and Myopia.

Authors:  Yan Zhang; Christine F Wildsoet
Journal:  Prog Mol Biol Transl Sci       Date:  2015-07-23       Impact factor: 3.622

8.  Gene expression signatures in tree shrew sclera in response to three myopiagenic conditions.

Authors:  Lin Guo; Michael R Frost; Li He; John T Siegwart; Thomas T Norton
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-10-21       Impact factor: 4.799

9.  Scleral permeability varies by mouse strain and is decreased by chronic experimental glaucoma.

Authors:  Mary E Pease; Ericka N Oglesby; Elizabeth Cone-Kimball; Joan L Jefferys; Matthew R Steinhart; Anthony J Kim; Justin Hanes; Harry A Quigley
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-04-21       Impact factor: 4.799

10.  Is emmetropia the natural endpoint for human refractive development? An analysis of population-based data from the refractive error study in children (RESC).

Authors:  Ian G Morgan; Kathryn A Rose; Leon B Ellwein
Journal:  Acta Ophthalmol       Date:  2010-12       Impact factor: 3.761

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.